ANSTO/ANZSNM Research Grant 2021

Applications are now closed for the 2021 Research Grant.

Closing Date: 31 December 2020.

To be eligible to apply for the Grant, please refer to the terms in the Guidelines attached below.

  • Research Grant 2021 - Invitation to Apply, click HERE to view
  • Research Grant 2021 - Guidelines, click HERE to view


ANSTO is Australia’s government-funded nuclear science organisation. Its vision is to deliver excellence in innovation, insight, and discovery through its people, partnerships, nuclear expertise and landmark infrastructure. In assessing applications for the grant, preference will be given to early career researchers in order to provide seed funding for pilot investigations that could lead on to further grant applications. The grant will be offered yearly but the evaluating committee reserves the right to not award the grant if there is no suitable application.

All aspects of nuclear medicine will be considered for this grant including, but not restricted to:

  • novel developments in radiopharmaceuticals;

  • hardware and software innovation;

  • epidemiology and audit activities;

  • pilot clinical trials;

  • retrospective studies on outcomes in diagnostic and therapeutic procedures in nuclear medicine;

  • education, training and professional development activities.

The ANSTO/ANZSNM Research Grant is intended to achieve one or more of the following:

  • approach a meaningful conclusion in one year;

  • assist investigators striving to establish new programs or new directions;

  • fund initial exploratory research for which external funding will be sought subsequently;

  • address circumscribed clinical problems of a sort unlikely to attract industry funding;

  • survey groups of patients to assess the success rate, sequelae, safety or any other aspect of diagnostic or radionuclide therapy protocols;

  • bridge the gap of a year between the completion of one external grant and the commencement of another.

The evaluating committee will consist of one representative from ANSTO, one member of the Society's Scientific Advisory Panel and the ANZSNM President or their delegate. The successful applicant/team is expected to acknowledge ANSTO’s and the Society’s support in any publications and provide a report to be published in the Gamma Gazette upon completion. The applicant will ideally present the outcome(s) of the research at the next ANZSNM ASM.


Dr William Tieu, SAHMRI
Cu61 and Cu61-ATSM production on a medical cyclotron

Dr Geoff Currie, Charles Sturt University
PET dose extravasation frequency and impact in the Australian context


Year Research Award Recipient Research Award Institution Research Award Title
 2019  Geoff Currie Charles Sturt University

PET dose extravasation frequency and impact in the Australian context

2017 Nelson Loh Sir Charles Gairdner Hospital, Perth Establishing an Australian reference range for striatal binding in patients with Parkinson's disease and healthy controls with 6-[18F]fluro-L3, 4-dihydroxyphenylalanine (F-DOPA) PET
2016 Nicholas Forwood Royal North Shore Hospital, Sydney In Vitro Studies of Cell Survival Comparing External Beam Radiotherapy to Radionuclides
2015 Peter Kench University of Sydney Diagnostic Reference Levels for patients undergoing PET/CT Scans in Australia and New Zealand
2014  Kenny Sek and Roslyn Francis Sir Charles Gairdner Hospital, Perth A pilot study of the utility of the combination of F18-FDG and F18-FCH PET imaging in hepatocellular carcinoma